Company

Company
Leadership

Leadership

Dong-Ho Kim / CEO

Career
  • Current) Adjunct Professor, Department of Chemistry, Pohang University of Science and Technology
  • Former) Genolution Founder, Co-CEO
  • Former) Postdoc, staff scientist, director of RNAi Core at Beckman Research Institute of the City of Hope
  • Former) Ph.D. in Microbiology from University of Texas at Austin
대표 논문
  • Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase
    (Alnyalm Pharmaceuticals 에 기술 이전)
  • Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
    (Dicerna Pharmaceuticals 에 기술 이전)
  • A novel defined TLR3 agonist as an effective vaccine adjuvant
  • The Defined TLR3 Agonist, Nexavant, Exhibits Anti-Cancer Efficacy and Potentiates Anti-PD-1 Antibody Therapy by Enhancing Immune Cell Infiltration

  • Seung-Beom Hong

    Head of Development Division, Head of Corporate Research Center

    • Former) Team Leader of Lead Validation Team, ISU Abxis

    • Former) Research Associate, University of Pennsylvania

    • Former) Research Fellow, National Institutes of Health

    • Former) Postdoctoral researcher, Samsung Biotechnology Research Institute

    • PhD in Biological Sciences, KAIST

  • Seung-Bin Cha

    Head of Research Division

    • Former) Quratis Senior Researcher

    • Former) Research Professor, Immune Disease Research Institute, Yonsei University College of Medicine

    • Former) Senior Researcher, National Institute of Health, Korea Centers for Disease Control and Prevention

    • DVM, PhD in Veterinary Microbiology, Seoul National University

  • Tae-Rim Yun

    CFO

    • Former) SK Planet Investment Management Team Leader

    • Former) SK Telecom Business Management Team Leader

    • Global MBA, Sungkyunkwan University

    • Graduated from Sungkyunkwan University, Department of Commerce

  • Kyung-Sik Jeon

    IP/Legal Department (Patent Attorney)

    • Former) Kolon Industries Intellectual Property Team Leader

    • Former) Member patent attorney at Yumi Patent Firm

    • Former) Partner patent attorney at Halla Patent Firm

    • Master's course in Biomolecular and Genetic Engineering, Graduate School of Life and Environmental Sciences, Korea University

    • Graduated from University of Seoul, Department of Life Sciences

  • Yo-Han Kim

    Non-Executive Director

    • Current) DSC Investment Executive Director

    • Former) IMM Investment

    • Former) Hanmi Pharmaceutical

    • Seoul National University Graduate School, Master of Pharmaceutical Sciences

    • Graduated from Seoul National University, Department of Pharmacy